Pipeline

Pipeline

Autifony’s pipeline includes clinical stage programmes for Fragile X and rare neurology and earlier stage programmes focused on Schizophrenia, Alzheimer’s Disease, Parkinson’s Disease, Fronto-Temporal Dementia and hearing loss

CompoundIndicationLead OptimizationPreclinical DevelopmentPhase IPhase II
AUT00206 (Kv3.1/Kv3.2)Fragile X Syndrome
AUT00201 (Kv3.1/Kv3.2)Orphan Neurology
Kv3.1/3.2 modulatorsSchizophrenia, Hearing Loss
Lysosomal ChannelParkinson’s Disease
Novel Genetically linked Ion ChannelAlzheimer's Disease Frontotemporal Dementia

Related News

18Dec

Autifony Therapeutics and Boehringer Ingelheim collaborate on a novel therapeutic approach to a range of CNS disorders

0 Comments
Collaboration with funding of development activities gives Boehringer Ingelheim exclusive option to purchase certain Autifony assets to treat serious CNS... Read More →
10Jul

Autifony Therapeutics receives Orphan Drug Designation for AUT00206 for Fragile X Syndrome

0 Comments
Autifony Therapeutics Limited (“Autifony”), which is pioneering the development of novel pharmaceutical treatments for serious disorders of the central nervous... Read More →
18May

Autifony Therapeutics initiates recruitment into schizophrenia clinical trial for first-in-class drug

0 Comments
Autifony Therapeutics Limited (“Autifony”), which is pioneering the development of novel pharmaceutical treatments for serious disorders of the central nervous... Read More →
10Jan

Autifony Therapeutics announces positive results from Phase I study of AUT00206, a first-in-class Kv3 modulator for treatment of schizophrenia

0 Comments
Autifony Therapeutics Limited (“Autifony”), which is pioneering the development of novel pharmaceutical treatments for serious disorders of the central nervous... Read More →
09Aug

Autifony Announces Results from Completed CLARITY-1, Phase IIa Trial of AUT00063 in Age-related Hearing Loss

0 Comments
Autifony Therapeutics Limited, which is pioneering the development of novel pharmaceutical treatments for hearing disorders and other serious disorders of... Read More →
Back to Top
Responsive Menu Pro Image Responsive Menu Clicked Image